Baxter International Inc.
NYSE:BAXMedical - Instruments & Supplies
Healthcare
$26.16 -5.23%
-$1.07 today
- Market cap
- $13.53B
- Beta
- 0.64
- P/E (TTM)
- -9.1
- EPS (TTM)
- -$2.13
- Dividend yield
- 1.03%
52W Low $15.73High $31.76
Volume 4.01M
Average 7.62M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
$845.00M
FY 2025 · Annual
-17.1% YoYInvesting Cash Flow
$2.84B
FY 2025 · Annual
Financing Cash Flow
-$4.22B
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 1.03B | (3.11B) | 181M | (326M) | (957M) |
| Depreciation & Amortization | 867M | 1.07B | 984M | 997M | 981M |
| Deferred Income Tax | (161M) | (260M) | (256M) | (262M) | 77M |
| Stock-Based Compensation | 146M | 140M | 115M | 114M | 117M |
| Change in Working Capital | (57M) | (606M) | 161M | (236M) | (108M) |
| Accounts Receivables | (170M) | (48M) | (38M) | (35M) | (132M) |
| Inventory | (27M) | (198M) | (128M) | (201M) | (119M) |
| Accounts Payables | 105M | (67M) | 92M | 112M | 3M |
| Other Working Capital | 35M | (293M) | 235M | (112M) | 140M |
| Other Non-Cash Items | 394M | 3.98B | 541M | 732M | 735M |
| Operating Cash Flow | 2.22B | 1.21B | 1.73B | 1.02B | 845M |
| Capital Expenditures | (691M) | (635M) | (436M) | (460M) | (522M) |
| Acquisitions (Net) | (10.5B) | (263M) | (6M) | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 34M | 0 |
| Other Investing Activities | (7M) | (33M) | 3.66B | (200M) | 3.35B |
| Investing Cash Flow | (11.2B) | (931M) | 3.21B | (626M) | 2.84B |
| Debt Repayment | 9.33B | (899M) | (2.94B) | (531M) | (3.79B) |
| Common Stock Issued | 187M | 127M | 95M | 71M | 30M |
| Common Stock Repurchased | (600M) | (32M) | 0 | 0 | 0 |
| Dividends Paid | (530M) | (573M) | (586M) | (590M) | (348M) |
| Other Financing Activities | (138M) | (61M) | (63M) | (31M) | (107M) |
| Financing Cash Flow | 8.25B | (1.44B) | (3.49B) | (1.08B) | (4.22B) |
| Effect of Forex Changes | (47M) | (76M) | 26M | (96M) | 84M |
| Net Change in Cash | (780M) | (1.23B) | 1.48B | (784M) | (446M) |
| Free Cash Flow | 1.53B | 576M | 1.29B | 559M | 323M |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$957.0M
+ D&A$981.0M
+ Stock-Based Comp$117.0M
+ Deferred Tax$77.0M
- Working Capital-$108.0M
+ Other Non-Cash$735.0M
= Operating Cash Flow$845.0M
- Capex-$522.0M
= Free Cash Flow$323.0M
Analysis
FY2025 free cash flow is $323.0M. FCF conversion is -33.8% of net income. Operating cash flow was $845.0M, with capex of -$522.0M. The largest bridge item is D&A at $981.0M.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Oct 29, 2026 | |
| 10-Q | Quarterly report | Oct 29, 2026 | |
| SC 13G/A | SC 13G/A filing | Oct 27, 2026 | |
| 3 | Initial statement of beneficial ownership | Oct 2, 2026 | |
| 3 | Initial statement of beneficial ownership | Sep 18, 2026 |
Does BAX generate free cash flow?
Baxter International Inc. (BAX) generated $323.00M of free cash flow in fiscal 2025.
How much operating cash flow does BAX produce?
Operating cash flow was $845.00M, before capital expenditures of $522.00M.
Continue the stock analysis
Jump to another research area for this company.